Kactus Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
197
- Latest Deal Type
-
2ndary - Private
- Investors
-
10
Kactus General Information
Description
Manufacturer of recombinant protein reagents, enzyme tools, and bio-raw materials designed for biopharmaceutical drug discovery, mRNA therapeutics, and cell and gene therapies. The company utilizes structure-guided protein engineering, mammalian cell expression systems, membrane protein stabilization, and GMP-grade enzyme manufacturing, providing biopharmaceutical enterprises, antibody developers, cell and gene therapy companies, and life science research institutions with complex target proteins, mRNA processing enzymes, CGT raw materials, and custom protein engineering services to facilitate targeted drug discovery and advanced biomanufacturing.
Contact Information
Website
www.kactusbio.cnCorporate Office
- 4th Floor, Building 8A
- Number 188 Xinjuanhuan Road, Minhang District
- Shanghai, 200000
- China
Corporate Office
- 4th Floor, Building 8A
- Number 188 Xinjuanhuan Road, Minhang District
- Shanghai, 200000
- China
Kactus Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Secondary Transaction - Private | 29-Mar-2023 | Completed | Generating Revenue | |||
| 6. Early Stage VC (Series B) | 28-Mar-2022 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series A1) | 08-Jul-2021 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A) | 28-Sep-2020 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 27-Feb-2020 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 20-Dec-2018 | $4.34M | $5.29M | Completed | Generating Revenue | |
| 1. Angel (individual) | 27-Apr-2018 | $953K | $953K | Completed | Startup |
Kactus Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Kactus Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Kactus Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AbogenBio | VC-Backed Company | Minority | ||
| Danaher Chuangsi Capital | Venture Capital | Minority | ||
| New Alliance Capital | Growth/Expansion | Minority | ||
| Shanghai Guofang Fund of Funds Equity Investment Management | Fund of Funds | Minority | ||
| Shanghai Lingang Economic Development | Limited Partner | Minority |
Kactus FAQs
-
When was Kactus founded?
Kactus was founded in 2018.
-
Where is Kactus headquartered?
Kactus is headquartered in Shanghai, China.
-
What is the size of Kactus?
Kactus has 197 total employees.
-
What industry is Kactus in?
Kactus’s primary industry is Biotechnology.
-
Is Kactus a private or public company?
Kactus is a Private company.
-
What is Kactus’s current revenue?
The current revenue for Kactus is .
-
How much funding has Kactus raised over time?
Kactus has raised $58.2M.
-
Who are Kactus’s investors?
AbogenBio, Danaher Chuangsi Capital, New Alliance Capital, Shanghai Guofang Fund of Funds Equity Investment Management, and Shanghai Lingang Economic Development are 5 of 10 investors who have invested in Kactus.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
